Most types of cancer are assigned a numbered stage based on the size of the tumor and how far it has spread. But leukemia does not usually form tumors, and it already involves the bone marrow and, in many cases, has also spread to other organs. The outlook for the person with acute lymphocytic leukemia (ALL) depends on other information, such as the subtype of ALL, the age of the patient, and lab test results.
The older French, American, and British (FAB) system to classify ALL was based only on the way the leukemia cells looked under the microscope after routine staining. This system has largely been replaced, as newer lab tests now allow doctors to better classify ALL.
These lab tests provide more detailed information about the subtype of ALL and the patient's outlook. They let doctors divide ALL into groups based on the type of lymphocyte (B cell or T cell) the leukemia cells come from and how mature the leukemia cells are.
The subtypes of ALL each carry a slightly different outlook, so ask your doctor what type you have and how it may affect your treatment.
As leukemia treatment has improved over the years, research has focused on why some patients have a better chance for cure than others. Certain factors, called prognostic factors, can give doctors a better idea of how likely standard treatment will be successful for an individual patient. These factors include
- The patient's age
- White blood cell count
- ALL subtype, certain test results
- How the ALL responds to treatment
The American Cancer Society has detailed information about these subtypes and prognostic factors in Leukemia - Acute Lymphocytic (Adults).
Last Revised: 02/22/2016